glp-1 colorado can be a gamechanger in regulating weight loss drugs | OPINION Colorado Pols Move to Clamp

Since the FDA approved Ozempic in 2017, the drugs manufacturer, Novo Nordisk, has not included warnings that the medication can cause gastroparesis in its prescription information

Obesity is associated with chronic low-grade inflammation, insulin resistance, and altered brain structure and function

While we await better data and guardrails, there will be more GLP-1 mass improvisation

While these injections have proven beneficial in managing type 2 diabetes and reducing HbA1c levels, they also contribute to cardiovascular health

However, the financial equation becomes very challenging if everyone who wants to be a bit leaner starts using these drugs

Additionally, some patients who have successfully lost weight on standard doses may consider microdosing GLP-1 as part of a maintenance strategy, particularly if they find that conventional doses continue to impact their weight when theyre ready to stabilize